Cerebrospinal fluid 2-hydroxyglutarate as a monitoring biomarker for IDH-mutant gliomas
Cécile Riviere-Cazaux, Jean M. Lacey, Lucas P. Carlstrom, William Laxen, Amanda Munoz-Casabella, Matthew D. Hoplin, Samar Ikram, Abdullah Bin Zubair, Katherine M. Andersen, Arthur E. Warrington, Paul A. Decker, Timothy J. Kaufmann, Jian Campian, Jeanette E. Eckel‐Passow, Sani H. Kizilbash, Silvia Tortorelli, Terry C. Burns
Topics & Concepts
Cerebrospinal fluidGliomaBiomarkerMutantCancer researchPathologyMedicineBiologyGeneticsGeneGlioma Diagnosis and TreatmentCancer, Hypoxia, and MetabolismBrain Metastases and Treatment